Severe Rhabdomyolysis as a Consequence of the Interaction of Fusidic Acid and Atorvastatin (Q42871519)

9 November 2017

title

Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin (English)

1 reference

9 November 2017

Severe Rhabdomyolysis as a Consequence of the Interaction of Fusidic Acid and Atorvastatin (English)

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

25 July 2024

1 reference

Ciara N. Magee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

25 July 2024

Samar A. Medani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

25 July 2024

Sean F. Leavey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

25 July 2024

Peter J. Conlon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

25 July 2024

Michael R. Clarkson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

25 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888103

25 July 2024

publication date

1 November 2010

1 reference

full work available at URL

9 November 2017

http://www.ajkd.org/article/S0272638610011790/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888103

https://api.elsevier.com/content/article/PII:S0272638610011790?httpAccept=text/xml

25 July 2024

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

https://api.elsevier.com/content/article/PII:S0272638610011790?httpAccept=text/plain

25 July 2024

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

American Journal of Kidney Diseases

25 July 2024

published in

1 reference

9 November 2017

volume

56

1 reference

9 November 2017

issue

5

1 reference

9 November 2017

page(s)

e11-5

1 reference

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

9 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Statin-associated myopathy

25 July 2024

3

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Statin safety: a systematic review

25 July 2024

4

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Cerivastatin and reports of fatal rhabdomyolysis

25 July 2024

5

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Exercise and diet reduce risk of diabetes, US study shows

25 July 2024

6

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Narrative review: statin-related myopathy

25 July 2024

7

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients

25 July 2024

8

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

25 July 2024

9

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

25 July 2024

10

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Inhibition of Cholesterol Synthesis by Squalene Synthase Inhibitors Does Not Induce Myotoxicityin Vitro

25 July 2024

11

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

25 July 2024

12

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone

25 July 2024

13

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Clinical Pharmacokinetics of Atorvastatin

25 July 2024

14

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

25 July 2024

15

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Mechanistic studies on metabolic interactions between gemfibrozil and statins

25 July 2024

16

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics

25 July 2024

17

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis

25 July 2024

19

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Acute rhabdomyolysis after atorvastatin and fusidic acid therapy

25 July 2024

20

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Rhabdomyolysis with atorvastatin and fusidic acid.

25 July 2024

21

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Rhabdomyolysis and acute renal graft impairment in a patient treated with simvastatin, tacrolimus, and fusidic acid

25 July 2024

22

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin

25 July 2024

23

1 reference

https://api.crossref.org/works/10.1053/J.AJKD.2010.07.011

25 July 2024

Identifiers

1 reference

9 November 2017

1 reference